Skip to main content
Clinical Trials/NCT01199107
NCT01199107CompletedPhase 3

Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)

Southern Methodist University2 sites in 1 country9 target enrollmentStarted: September 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
9
Locations
2
Primary Endpoint
PTSD Symptoms

Study Overview

Brief Summary

The purpose of this study is to examine the efficacy of exercise in comparison to wellness education to determine if they can improve the effects of prolonged exposure therapy (PE) in reducing symptoms of anxiety associated with Post-traumatic Stress Disorder (PTSD). In addition, the two strategies (i.e., exercise and wellness education) will be compared in terms of improvements in sleep as well as levels of brain-derived neurotrophic factor (BDNF). BDNF is a protein that helps to support the survival of existing neurons and stimulate the growth new neurons and synapses. BDNF is important to learning and memory in general and therefore may be associated with the learning and memory as it relates to PE and corresponding symptom PTSD improvement.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 54 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • You have PTSD
  • You are between the age of 18 and 54 if female or between ages 18 and 44 if male.
  • You have written physician approval/medical clearance to participate in an exercise protocol.
  • Are currently taking no psychotropic medications or are able and willing to discontinue these medications prior to the first PE session.

Exclusion Criteria

  • You are currently participating in a structured exercise program
  • You have severe depression
  • You have any history of bipolar disorder, psychotic disorder, or obsessive compulsive disorder;
  • You have a diagnosis of eating disorder, or substance abuse or dependence (excluding nicotine) within the past six months
  • You have any history of a suicide attempt, or are at significant risk of self-harm or harm to others
  • You have ever been diagnosed with organic brain syndrome, mental retardation, or other cognitive dysfunction

Outcomes

Primary Outcomes

PTSD Symptoms

Time Frame: 3 months

Self-report measure that assesses PTSD Symptoms. Will be assessed at each visit throughout the 3 month protocol.

Secondary Outcomes

  • BDNF (by blood sample)(3 months)
  • Sleep Quality(3 months)
  • General Mood and Anxiety Symptoms(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jasper Smits, Ph.D.

Principal Investigator

Southern Methodist University

Study Sites (2)

Loading locations...

Similar Trials